LobbyingKaruna Therapeutics lobbying by quarter
Karuna Therapeutics's latest lobbying report covers Q2 2024, at $100K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Karuna Therapeutics
- Latest quarter
- No record
- Q2 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $80K | 1 |
| Q1 2023 | $50K | 1 |
| Q2 2023 | $50K | 1 |
| Q3 2023 | $100K | 2 |
| Q4 2023 | $100K | 2 |
| Q1 2024 | $100K | 2 |
| Q2 2024 | $100K | 2 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
Policy issues the reports name
- Health issues10 reports
A report that names several issues counts once for each.
Who was lobbied
- SENATE8 reports
- HOUSE OF REPRESENTATIVES3 reports
Firms it paid
| Firm | ||
|---|---|---|
| W Strategies | $380K | 7 quarters |
| Avenue Solutions | $200K | 4 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DARREN WILLCOX | Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director | Q2 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/07/22for Q2 2024 | Avenue Solutions | $50K |
| 24/07/22for Q2 2024 | W Strategies | $50K |
| 24/04/22for Q1 2024 | W Strategies | $50K |
| 24/04/22for Q1 2024 | Avenue Solutions | $50K |
| 24/01/22for Q4 2023 | Avenue Solutions | $50K |
| 24/01/18for Q4 2023 | W Strategies | $50K |
| 23/10/20for Q3 2023 | W Strategies | $50K |
| 23/10/20for Q3 2023 | Avenue Solutions | $50K |
| 23/08/18for Q3 2023 | Avenue Solutions | Under $5,000 |
| 23/07/20for Q2 2023 | W Strategies | $50K |
| 23/04/20for Q1 2023 | W Strategies | $50K |
| 23/01/19for Q4 2022 | W Strategies | $80K |